ATE388954T1 - Bestimmte substituierte spirocyclische lactame und deren verwendung als pharmazeutika - Google Patents
Bestimmte substituierte spirocyclische lactame und deren verwendung als pharmazeutikaInfo
- Publication number
- ATE388954T1 ATE388954T1 AT04765790T AT04765790T ATE388954T1 AT E388954 T1 ATE388954 T1 AT E388954T1 AT 04765790 T AT04765790 T AT 04765790T AT 04765790 T AT04765790 T AT 04765790T AT E388954 T1 ATE388954 T1 AT E388954T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceuticals
- lactames
- certain substituted
- substituted spirocyclic
- spirocyclic
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- QAYAMAFOQWTHOB-UHFFFAOYSA-N 2-(6-oxo-1,7-diazaspiro[4.4]nonan-7-yl)propanamide Chemical class O=C1N(C(C)C(N)=O)CCC11NCCC1 QAYAMAFOQWTHOB-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0323204.8A GB0323204D0 (en) | 2003-10-03 | 2003-10-03 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE388954T1 true ATE388954T1 (de) | 2008-03-15 |
Family
ID=29415468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04765790T ATE388954T1 (de) | 2003-10-03 | 2004-10-04 | Bestimmte substituierte spirocyclische lactame und deren verwendung als pharmazeutika |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20070015781A1 (de) |
| EP (1) | EP1670803B1 (de) |
| JP (1) | JP4549350B2 (de) |
| CN (1) | CN1863804B (de) |
| AT (1) | ATE388954T1 (de) |
| AU (1) | AU2004279553C1 (de) |
| BR (1) | BRPI0415015A (de) |
| CA (1) | CA2540249A1 (de) |
| DE (1) | DE602004012426T2 (de) |
| ES (1) | ES2300815T3 (de) |
| GB (1) | GB0323204D0 (de) |
| MX (1) | MXPA06003645A (de) |
| PL (1) | PL1670803T3 (de) |
| PT (1) | PT1670803E (de) |
| WO (1) | WO2005035535A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2507484A1 (en) * | 2002-11-27 | 2004-06-17 | Elan Pharmaceuticals, Inc. | Substituted ureas and carbamates |
| AR053902A1 (es) * | 2005-06-14 | 2007-05-23 | Schering Corp | Inhibidores de aspartil proteasa heterociclicos macrociclicos |
| JP2009502786A (ja) * | 2005-07-18 | 2009-01-29 | メルク エンド カムパニー インコーポレーテッド | アルツハイマー病を治療するためのスピロピペリジンβ−セクレターゼ阻害剤 |
| US7745484B2 (en) * | 2005-11-21 | 2010-06-29 | Amgen Inc. | Beta-secretase modulators and methods of use |
| BRPI0918868B8 (pt) | 2008-09-18 | 2021-05-25 | Naurex Inc | compostos moduladores do receptor de nmda e composições compreendendo os mesmos |
| GB201122113D0 (en) | 2011-12-22 | 2012-02-01 | Convergence Pharmaceuticals | Novel compounds |
| US9758525B2 (en) | 2013-01-29 | 2017-09-12 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
| EP2951186B1 (de) | 2013-01-29 | 2018-07-25 | Aptinyx Inc. | Spiro-lactam-nmda-rezeptormodulatoren und verwendungen davon |
| PE20151416A1 (es) | 2013-01-29 | 2015-10-10 | Naurex Inc | Moduladores de receptores nmda de espiro-lactama y sus usos |
| KR102410989B1 (ko) | 2013-01-29 | 2022-06-17 | 앱티닉스 인크. | 스피로-락탐 nmda 수용체 조절인자 및 그의 용도 |
| JP2016506962A (ja) | 2013-01-29 | 2016-03-07 | ノーレックス, インコーポレイテッドNaurex, Inc. | スピロラクタム系ｎｍｄａ受容体モジュレーターおよびその使用 |
| WO2017201285A1 (en) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| PE20190174A1 (es) | 2016-05-19 | 2019-02-01 | Aptinyx Inc | Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos |
| WO2018026798A1 (en) | 2016-08-01 | 2018-02-08 | Aptinyx Inc. | Spiro-lactam nmda modulators and methods of using same |
| IL286107B2 (en) | 2016-08-01 | 2024-09-01 | Aptinyx Inc | Spiro-lactam nmda receptor modulators and usesthereof |
| AU2017306158B2 (en) | 2016-08-01 | 2021-10-14 | Aptinyx Inc. | Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof |
| KR102465758B1 (ko) | 2016-08-01 | 2022-11-09 | 앱티닉스 인크. | 스피로-락탐 nmda 수용체 조정제 및 그의 용도 |
| JP7036792B2 (ja) | 2016-08-01 | 2022-03-15 | アプティニックス インコーポレイテッド | スピロ－ラクタムｎｍｄａ受容体修飾因子およびその使用 |
| PE20210455A1 (es) | 2018-01-31 | 2021-03-08 | Aptinyx Inc | Moduladores del receptor nmda espiro-lactama y usos de los mismos |
| US20220267341A1 (en) * | 2019-06-24 | 2022-08-25 | Naurex Inc. | Solid forms of tert-butyl (s)-2((2s,3r)-1-amino-3-hydroxy-1-oxobu tan-2-yl)-1-oxo-2, 5-diazaspiro [3.4] octan e-5-carboxylate and methods of preparing them |
| US12012413B2 (en) | 2019-11-11 | 2024-06-18 | Tenacia Biotechnology (Hong Kong) Co., Limited | Methods of treating painful diabetic peripheral neuropathy |
| US20240174673A1 (en) * | 2022-10-26 | 2024-05-30 | Protego Biopharma, Inc. | Spirocycle Containing Pyridine Compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534520A (en) * | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
| PT970957E (pt) * | 1998-06-12 | 2002-02-28 | Hoffmann La Roche | Derivados de diaza-espiro¬3,5|nonamo |
| EP1140846B1 (de) * | 1999-01-06 | 2006-04-05 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Inhibitoren für asparagin-proteasen |
| EP1389194A2 (de) * | 2001-04-27 | 2004-02-18 | Vertex Pharmaceuticals Incorporated | Bace-inhibitoren |
| BRPI0519148A2 (pt) * | 2004-12-20 | 2008-12-30 | Sigma Tau Ind Farmaceuti | inibidores de homodimerizaÇço de myd88 |
-
2003
- 2003-10-03 GB GBGB0323204.8A patent/GB0323204D0/en not_active Ceased
-
2004
- 2004-10-04 AT AT04765790T patent/ATE388954T1/de not_active IP Right Cessation
- 2004-10-04 EP EP04765790A patent/EP1670803B1/de not_active Expired - Lifetime
- 2004-10-04 BR BRPI0415015-5A patent/BRPI0415015A/pt not_active IP Right Cessation
- 2004-10-04 CA CA002540249A patent/CA2540249A1/en not_active Abandoned
- 2004-10-04 PL PL04765790T patent/PL1670803T3/pl unknown
- 2004-10-04 MX MXPA06003645A patent/MXPA06003645A/es active IP Right Grant
- 2004-10-04 JP JP2006530082A patent/JP4549350B2/ja not_active Expired - Fee Related
- 2004-10-04 CN CN2004800288403A patent/CN1863804B/zh not_active Expired - Fee Related
- 2004-10-04 ES ES04765790T patent/ES2300815T3/es not_active Expired - Lifetime
- 2004-10-04 PT PT04765790T patent/PT1670803E/pt unknown
- 2004-10-04 AU AU2004279553A patent/AU2004279553C1/en not_active Ceased
- 2004-10-04 DE DE602004012426T patent/DE602004012426T2/de not_active Expired - Lifetime
- 2004-10-04 US US10/574,536 patent/US20070015781A1/en not_active Abandoned
- 2004-10-04 WO PCT/EP2004/011054 patent/WO2005035535A1/en not_active Ceased
-
2007
- 2007-06-26 US US11/823,311 patent/US7655686B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2300815T3 (es) | 2008-06-16 |
| CN1863804A (zh) | 2006-11-15 |
| CA2540249A1 (en) | 2005-04-21 |
| US20070265328A1 (en) | 2007-11-15 |
| HK1092472A1 (en) | 2007-02-09 |
| EP1670803A1 (de) | 2006-06-21 |
| MXPA06003645A (es) | 2006-06-05 |
| PT1670803E (pt) | 2008-04-23 |
| AU2004279553C1 (en) | 2009-07-23 |
| EP1670803B1 (de) | 2008-03-12 |
| DE602004012426D1 (de) | 2008-04-24 |
| BRPI0415015A (pt) | 2006-11-07 |
| PL1670803T3 (pl) | 2008-08-29 |
| JP4549350B2 (ja) | 2010-09-22 |
| JP2007509038A (ja) | 2007-04-12 |
| AU2004279553A1 (en) | 2005-04-21 |
| DE602004012426T2 (de) | 2009-03-26 |
| CN1863804B (zh) | 2010-05-26 |
| AU2004279553B2 (en) | 2009-03-12 |
| US7655686B2 (en) | 2010-02-02 |
| WO2005035535A1 (en) | 2005-04-21 |
| US20070015781A1 (en) | 2007-01-18 |
| GB0323204D0 (en) | 2003-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE388954T1 (de) | Bestimmte substituierte spirocyclische lactame und deren verwendung als pharmazeutika | |
| ATE435210T1 (de) | Tetrahydroisochinolylacetamidderivate zur verwendung als orexinrezeptorantagonisten | |
| SE0202133D0 (sv) | Novel compounds | |
| ATE496884T1 (de) | Sulphonylaminoessigsaeure derivate und deren verwendung als orexin rezeptor antagoniste | |
| ATE547395T1 (de) | Aminopropanol-derivate als modulatoren des sphingosin-1-phosphat-rezeptors | |
| MY140693A (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| GEP20084329B (en) | 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension | |
| DE602005013248D1 (de) | Amidderivate von 3-phenyldihydropyrimidoä4,5-düpyrimidinonen, deren herstellung und verwendung als pharmazeutische mittel | |
| DE602004001857D1 (de) | Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen | |
| ATE469892T1 (de) | Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung | |
| BR0315547A (pt) | Derivados de quinolina como antagonistas de crth2 | |
| ATE448225T1 (de) | Aza-bicycloalkylether und deren verwendung als alpha7-nachr agonisten | |
| SE0302116D0 (sv) | Novel compounds | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| NO20063355L (no) | Nye trisykliske spiroderivater som modulatorer for kemokinreseptoraktivitet | |
| MY142474A (en) | 1h-quinazoline-2,4-diones | |
| ATE383345T1 (de) | Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten. | |
| MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
| ATE429421T1 (de) | Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten | |
| DE69920455D1 (de) | Bis-indolederivate und ihre verwendung als entzündungshemmende mittel | |
| TW200714598A (en) | Urea derivatives, methods for their manufacture, and uses therefor | |
| SE0303090D0 (sv) | Novel compounds | |
| UA80814C2 (en) | Heterocyclic oxime compounds, a process for their preparation (variants) and pharmaceutical compositions containing them, intermediate | |
| BRPI0409958A (pt) | quinolinas de benzofuranil- e benzotienil-piperazinil quinolinas e métodos para o seu uso | |
| NO20063562L (no) | Fusjonerte heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1670803 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |